PreprintLicence not statedChemRxiv
Integrated Computational Design and Multistage Virtual Screening for the Prioritization of Putative USP5 Catalytic-Cleft Inhibitors
7 affiliations
- 1Department of Pharmaceutical Sciences
- 2Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University
- 3Cancer Biology Graduate Program
- 4Wayne State University School of Medicine
- 5MD/PhD Program
- 6Department of Oncology
- 7Barbara Ann Karmanos Cancer Institute
Related
- Integrated machine learning, pharmacophore screening, and structure-based computational approaches for the identification of novel JAK3 inhibitors
- Old Drugs, New Targets: Multi-parameter computational prioritization of FDA‑approved, brain‑penetrant drugs as isoform‑selective GSK‑3β inhibitors for Alzheimer’s disease
- Integrated Experimental and Computational Evaluation of Tri(p‐tolyl)phosphonium–Hydrazide Salts as AChE Inhibitors With Antimicrobial and Antibiofilm Activity Against Resistant Acinetobacter baumannii
- Integrated virtual screening and in vitro evaluation identify potential c-Myc/max complex inhibitors for colorectal cancer
- Identification of new fucosyltransferase-8 inhibitors: An integrated biochemical, biophysical, and computational approach
BibTeX
@misc{sahni2026integrated,
title = {{Integrated Computational Design and Multistage Virtual Screening for the Prioritization of Putative USP5 Catalytic-Cleft Inhibitors}},
author = {Shivansh Sahni and Kian Hershberger and Yubin Ge and Navnath S. Gavande},
howpublished = {ChemRxiv},
year = {2026},
month = nov,
doi = {10.26434/chemrxiv.15011855/v1},
url = {https://chemrxiv.org/doi/full/10.26434/chemrxiv.15011855/v1},
}
RIS
TY - UNPB
TI - Integrated Computational Design and Multistage Virtual Screening for the Prioritization of Putative USP5 Catalytic-Cleft Inhibitors
AU - Shivansh Sahni
AU - Kian Hershberger
AU - Yubin Ge
AU - Navnath S. Gavande
PY - 2026
DA - 2026/11/09
PB - ChemRxiv
DO - 10.26434/chemrxiv.15011855/v1
UR - https://chemrxiv.org/doi/full/10.26434/chemrxiv.15011855/v1
ER -